What this study is
Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.
What's being tested
- Enhanced CGM Interventions
Intervention · OTHER
The study intervention involves creating a streamlined workflow for CGM prescribing that does not restrict the treatment options available to patients or clinicians. SPARK-CGM implementation strategy includes three core practice transformations: (1) building clinic infrastructure by establishing CGM prescription workflows, and by training clinic staff to place CGM devices at the point of care, (2) provider training on accessing and using CGM data effectively in practice, and (3) regular feedback on prescription rates across the network.
- Standard of Care
Intervention · OTHER
Usual care
Study details
- Official title
- Supporting Primary Care Adoption, Resources, and Knowledge for Continuous Glucose Monitoring
- Sponsor
- Montefiore Medical Center
- Conditions
- Diabetes Mellitus
- Enrolling
- 20,000 people
- Starts
- 2026-05
- Est. completion
- 2028-05
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedAll participants
You may qualify if
- Clinic level:
- All adult Montefiore primary care sites
- Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff
You can't join if
- Clinic level:
- Sites participating in pilot phase of CGM initiative
Patient level
You may qualify if
- Age 18 years or older
- Receive primary care at participating sites
- Diagnosis of any diabetes mellitus
- Treated with insulin therapy
You can't join if
- Existing CGM prescription within 24 months before the study start
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMontefiore Medical Group (MMG)
The Bronx, New York, United States
Study team
Sponsor
Montefiore Medical Center
Study ID 2025-16972
Principal investigator
Jovan Milosavljevic, MD
Montefiore Medical Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.